- Acumen Powered by Robins Kaplan LLP®
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
June 17, 2024Emily Tremblay Named IP Rising Star by Euromoney in 2024 Women in Business Law Awards
-
June 17, 2024Three Robins Kaplan Partners Named BTI Client Service All-Stars
-
June 13, 2024Brendan Johnson Named South Dakota Trial Lawyer of The Year
-
June 27, 2024Sex Abuse Litigation
-
June 10-11, 20242024 Probate and Trust Law Section Conference
-
June 11, 2024FBA 2024 Federal Practice Seminar
-
June 2024Robins Kaplan Secures Landmark $7.75 Million Verdict in Aerosol Duster Misuse Case
-
June 2024To Seize or Not to Seize: Campus Protests and Police Uses of Force
-
June 2024Communicating Your Estate Plan: A Helpful Tool, Not a Fix-All
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Generic Launches
Abbreviated New Drug Applications and 505(b)(2) Applications
Third Quarter
![GENERICally Speaking](/-/media/images/newsletters/generically-speaking-social-graphics/generic_390x160.png?la=en&h=160&w=390&la=en&hash=7C4F410F9639FA5CC4261D8C8A36AB07)
This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug Applications and 505(b)(2) Applications.
Reference Listed Drug | ANDA Holder | Generic Drug Name | ANDA Applicant(s) |
Indication | Launch Date |
---|---|---|---|---|---|
Klor-Con | Upsher-Smith | potassium chloride | Hetero / Camber | used to treat patients with hypokalemia, with or without metabolic alkalosis; in digitalis intoxication; and in patients with hypokalemic familial periodic paralysis | 7/6/2021 |
Ambien CR | Sanofi | zolpidem | Breckenridge | used to treat insomnia in adults | 7/8/2021 |
Lescol XL | Novartis | fluvastatin | Lannett | used as an adjunctive therapy with changes to diet to lower cholesterol, slow the progression of heart disease, and reduce the risk of needing procedures to improve blood flow to the heart | 7/12/2021 |
Kerydin | Anacor | tavaborole | Lupin | used topically to treat onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes | 7/13/2021 |
Zytiga | Johnson & Johnson | abiraterone | Apotex | used to treat metastatic prostate cancer | 7/14/2021 |
Feraheme | AMAG/Covis | ferumoxytol | Sandoz | used to treat iron deficiency anemia (IDA) in adult patients who have an intolerance to oral iron or have had an unsatisfactory response to oral iron, or who have chronic kidney disease | 7/16/2021 |
Revatio | Pfizer | sildenafil | Hetero / Camber | used to treat erectile dysfunction (impotence) in men | 7/19/2021 |
Chantix | Pfizer | varenicline | Apotex | used as an aid to smoking cessation treatment | 7/20/2021 |
Levitra | Bayer | vardenafil | Alembic | used to treat erectile dysfunction | 7/30/2021 |
Extina | Mylan | ketoconazole | Xiromed | used topically to treat seborrheic dermatitis in immunocompetent patients 12 years of age and older | 8/2/2021 |
Lioresal | Novartis | baclofen | Hetero / Camber | used to treat muscle pain, spasms, and stiffness in people with multiple sclerosis or spinal cord injury or disease | 8/2/2021 |
Duexis | Horizon | ibuprofen / famotidine | Alkem | used for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for those indications | 8/4/2021 |
Kloxxado | Hikma | naloxone nasal spray | Hikma | used in an emergency to treat known or suspected opioid overdose for adult and pediatric patients | 8/4/2021 |
Taysofy | AbbVie | ethinyl estradiol / norethindrone / ferrous fumarate | Amneal | used to prevent pregnancy | 8/5/2021 |
Isuprel | Bausch & Lomb | isoproterenol | Amring | used for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy | 8/5/2021 |
Tegretol XR | Novartis | carbamazepine | Upsher-Smith | used as an anticonvulsant and specific analgesic for trigeminal neuralgia | 8/16/2021 |
Lovenox | Sanofi | enoxaparin | Zydus | used for prophylaxis of deep vein thrombosis in patients undergoing abdominal, hip or knee replacement surgery | 8/17/2021 |
Levophed | Hospira | noreinephrine bitartrate | Breckenridge | used to restore blood pressure control in certain acute hypotensive states | 8/20/2021 |
Clindagel | Bausch & Lomb | clindamycin | Solaris | used topically to treat acne vulgaris | 8/23/2021 |
Sodium Acetate | Pfizer | sodium acetate | Milla | used as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake | 8/26/2021 |
Axiron | Eli Lilly | testosterone | Acrux / Dash Pharma | used for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone | 8/26/2021 |
Northera | Lundbeck | droxidopa | Aurobindo | used to treat orthostatic dizziness, light headedness in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy | 8/27/2021 |
CellCept | Roche | mycophenolate | Lannett | used for the prophylaxis of organ rejection in recipients of allogeneic kidney, heart or liver transplants, and should be used in combination with other immune-suppressants | 8/30/2021 |
Librax | Bausch & Lomb | chlordiazepoxide / clidinium bromide | Dr. Reddy's | used to control emotional and somatic factors in gastrointestinal disorders. It may also be used as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis | 8/31/2021 |
Jadenu | Novartis | deferasirox | Hetero / Camber | used to treat iron overload caused by blood transfusions in adults and children at least 2 years old; also used to treat chronic iron overload syndrome caused by a genetic blood disorder in adults and children who are at least 10 years old | 8/31/2021 |
Paxil O.S. | Glaxo | paroxetine | ANI / Novitium | used to treat depression, panic attacks, obsessive-compulsive disorder (OCD), anxiety disorders, and post-traumatic stress disorder | 9/10/2021 |
Duexis | Horizon | ibuprofen / famotidine | Lupin | used for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for those indications | 9/15/2021 |
Trisenox | Teva | arsenic trioxide | Amneal | used for induction of remission and consolidation in patients with APL who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression | 9/16/2021 |
Bystolic | AbbVie | nebivilol | ANI | used to treat hypertension, to lower blood pressure and may be used alone or in combination with other antihypertensive agents | 9/17/2021 |
Bystolic | AbbVie | nebivilol | Hetero / Camber | used to treat hypertension, to lower blood pressure and may be used alone or in combination with other antihypertensive agents | 9/17/2021 |
Chantix | Pfizer | varenicline | Par | used to aid smoking cessation treatment | 9/22/2021 |
Taxotere | Sanofi | docetaxel | Xiromed / Insud | used to treat patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy | 9/27/2021 |
Northera | Lundbeck | droxidopa | Lupin | used to treat orthostatic dizziness, light headedness in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy | 9/28/2021 |
Absorica | Sun | isotretinoin | Mayne | used to treat severe recalcitrant nodular acne | 9/29/2021 |
Butrans | Purdue | buprenorphine | Apotex | used to manage pain severe enough to require daily, around-the- clock, long-term opioid treatment and for which alternative treatment options are inadequate | 9/30/2021 |
GENERICally Speaking Hatch Waxman Bulletin
GENERICally Speaking Hatch Waxman Bulletin
READ MORE Related Publications
First Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
March 25, 2024
Endo Ventures Unlimited Co. v. Nexus Pharms. Inc.
GENERICally Speaking Hatch Waxman Bulletin
March 22, 2024
Mallinckrodt plc v. Airgas Therapeutics LLC
GENERICally Speaking Hatch Waxman Bulletin
March 8, 2024
UCB, Inc. v. Mylan Techs. Inc.
GENERICally Speaking Hatch Waxman Bulletin
March 5, 2024
Genentech, Inc. v. Sandoz, Inc.
GENERICally Speaking Hatch Waxman Bulletin
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.